These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 30623893)
1. Prognostic Value of Upregulation of Myristoylated Alanine-Rich C-Kinase Substrate in Gastric Cancer. Quan R; Ning Z; Wang Y; Yu W; Zhu H Med Sci Monit; 2019 Jan; 25():279-287. PubMed ID: 30623893 [TBL] [Abstract][Full Text] [Related]
2. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma. Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157 [TBL] [Abstract][Full Text] [Related]
3. MARCKS protein overexpression in inflammatory breast cancer. Manai M; Thomassin-Piana J; Gamoudi A; Finetti P; Lopez M; Eghozzi R; Ayadi S; Lamine OB; Manai M; Rahal K; Charafe-Jauffret E; Jacquemier J; Viens P; Birnbaum D; Boussen H; Chaffanet M; Bertucci F Oncotarget; 2017 Jan; 8(4):6246-6257. PubMed ID: 28009981 [TBL] [Abstract][Full Text] [Related]
4. Myristoylated alanine rich protein kinase C substrate is a potential cancer prognostic factor that regulates cell migration and invasion in glioblastoma. Xiang W; Peng T; Ming Y; Li S; Wang K; Wang H; Chen L; Zhou J Oncol Rep; 2019 Apr; 41(4):2464-2470. PubMed ID: 30816497 [TBL] [Abstract][Full Text] [Related]
5. Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway. Techasen A; Loilome W; Namwat N; Takahashi E; Sugihara E; Puapairoj A; Miwa M; Saya H; Yongvanit P Cancer Sci; 2010 Mar; 101(3):658-65. PubMed ID: 20047593 [TBL] [Abstract][Full Text] [Related]
6. Targeting the effector domain of the myristoylated alanine rich C-kinase substrate enhances lung cancer radiation sensitivity. Rohrbach TD; Jarboe JS; Anderson JC; Trummell HQ; Hicks PH; Weaver AN; Yang ES; Oster RA; Deshane JS; Steele C; Siegal GP; Bonner JA; Willey CD Int J Oncol; 2015 Mar; 46(3):1079-88. PubMed ID: 25524703 [TBL] [Abstract][Full Text] [Related]
7. A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis. Chen CH; Thai P; Yoneda K; Adler KB; Yang PC; Wu R Oncogene; 2014 Jul; 33(28):3696-706. PubMed ID: 23955080 [TBL] [Abstract][Full Text] [Related]
8. MARCKS regulates growth and radiation sensitivity and is a novel prognostic factor for glioma. Jarboe JS; Anderson JC; Duarte CW; Mehta T; Nowsheen S; Hicks PH; Whitley AC; Rohrbach TD; McCubrey RO; Chiu S; Burleson TM; Bonner JA; Gillespie GY; Yang ES; Willey CD Clin Cancer Res; 2012 Jun; 18(11):3030-41. PubMed ID: 22619307 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target. Chen CH; Fong LWR; Yu E; Wu R; Trott JF; Weiss RH Oncogene; 2017 Jun; 36(25):3588-3598. PubMed ID: 28166200 [TBL] [Abstract][Full Text] [Related]
10. Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value. Doghri R; Manai M; Finetti P; Driss M; Agavnian E; Lopez M; Elghardallou M; Charafe-Jauffret E; Manai M; Chaffanet M; Birnbaum D; Mrad K; Bertucci F Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295532 [TBL] [Abstract][Full Text] [Related]
11. Targeting myristoylated alanine-rich C kinase substrate phosphorylation site domain in lung cancer. Mechanisms and therapeutic implications. Chen CH; Statt S; Chiu CL; Thai P; Arif M; Adler KB; Wu R Am J Respir Crit Care Med; 2014 Nov; 190(10):1127-38. PubMed ID: 25318062 [TBL] [Abstract][Full Text] [Related]
12. Fibroblast Migration Is Regulated by Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Protein. Ott LE; Sung EJ; Melvin AT; Sheats MK; Haugh JM; Adler KB; Jones SL PLoS One; 2013; 8(6):e66512. PubMed ID: 23840497 [TBL] [Abstract][Full Text] [Related]
13. MARCKS protein overexpression is associated with poor prognosis in male breast cancer. Manai M; Abdeljaoued S; Goucha A; Adouni O; Bettaieb I; Bouzaien H; Rahal K; Birnbaum D; Bertucci F; Gamoudi A Cancer Biomark; 2019; 26(4):513-522. PubMed ID: 31771045 [TBL] [Abstract][Full Text] [Related]
14. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer. Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144 [TBL] [Abstract][Full Text] [Related]
15. LINC01268 promotes epithelial-mesenchymal transition, invasion and metastasis of gastric cancer Tang LH; Ye PC; Yao L; Luo YJ; Tan W; Xiang WP; Liu ZL; Tan L; Xiao JW World J Gastrointest Oncol; 2023 Aug; 15(8):1366-1383. PubMed ID: 37663944 [TBL] [Abstract][Full Text] [Related]
16. Cell type-specific upregulation of myristoylated alanine-rich C kinase substrate and protein kinase C-alpha, -beta I, -beta II, and -delta in microglia following kainic acid-induced seizures. Eun SY; Kim EH; Kang KS; Kim HJ; Jo SA; Kim SJ; Jo SH; Kim SJ; Blackshear PJ; Kim J Exp Mol Med; 2006 Jun; 38(3):310-9. PubMed ID: 16819290 [TBL] [Abstract][Full Text] [Related]
17. Altered expression and phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) in postmortem brain of suicide victims with or without depression. Pandey GN; Dwivedi Y; Ren X; Rizavi HS; Roberts RC; Conley RR; Tamminga C J Psychiatr Res; 2003; 37(5):421-32. PubMed ID: 12849934 [TBL] [Abstract][Full Text] [Related]
18. Expression of the major protein kinase C substrate, the acidic 80-kilodalton myristoylated alanine-rich C kinase substrate, increases sharply when Swiss 3T3 cells move out of cycle and enter G0. Herget T; Brooks SF; Broad S; Rozengurt E Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2945-9. PubMed ID: 8464911 [TBL] [Abstract][Full Text] [Related]
19. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver. Masaki T; Tokuda M; Yoshida S; Nakai S; Morishita A; Uchida N; Funaki T; Kita Y; Funakoshi F; Nonomura T; Himoto T; Deguchi A; Kimura Y; Izuishi K; Wakabayashi H; Usuki H; Yoshiji H; Watanabe S; Kurokohchi K; Kuriyama S Int J Oncol; 2005 Mar; 26(3):661-71. PubMed ID: 15703821 [TBL] [Abstract][Full Text] [Related]
20. Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival. Bickeböller M; Tagscherer KE; Kloor M; Jansen L; Chang-Claude J; Brenner H; Hoffmeister M; Toth C; Schirmacher P; Roth W; Bläker H Oncogene; 2015 Feb; 34(9):1150-9. PubMed ID: 24662837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]